Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Maternity
  4. Back
  5. Antenatal, general
  6. Vaginal Birth after Caesarean Section (VBAC) (415)
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Vaginal Birth after Caesarean Section (VBAC) (415)

Warning
Please report any inaccuracies or issues with this guideline using our online form

Pregnancy and childbirth following Caesarean Section:

The decision about mode of birth should consider:

  • Maternal preferences and priorities.
  • The woman’s past obstetric history.
  • General discussion of the overall risks and benefits of Vaginal Birth after Caesarean Section (VBAC) and Elective Repeat Caesarean Section (ERCS).
  • All women suitable for VBAC should be offered this option

Women who want VBAC should be supported and:                                

  • Be informed that women who labour spontaneously with a previous section but without a previous vaginal birth have a 72-75% chance of a vaginal birth.
  • Be informed that women who labour spontaneously with both previous CS and a previous vaginal birth are more likely to give birth vaginally with an 85-90% chance of success.
  • Be informed that uterine rupture is very rare but increased with VBAC: about 1 per 10,000 repeat CS and 50 per 10,000 (1 in 200) VBAC.
  • Be informed that intrapartum infant death is rare (about 10 per 10,000 – the same as the risk for women in their first pregnancy), but increased compared with planned repeat CS (about 1 per 10,000).
  • Be advised to have electronic fetal monitoring during labour: indicating this is unit policy if VBAC attempted.
  • Should labour in a unit where there is immediate access to CS and on-site blood transfusion.
  • If having induction of labour should be aware of the increased risk of uterine rupture (80 per 10,000) if mechanical methods (amniotomy or Foley’s catheter) are used compared to 240 per 10,000 if prostaglandins are used).

Management of VBAC

ANTENATAL CLINIC

  • An individualized risk assessment should be made for each woman and full documentation of delivery plan made in the notes.
  • Previous notes should be reviewed. If not available or the woman delivered in another unit then information regarding her previous deliveries should be sought early in the antenatal period.
  • Consultant input during the antenatal period should be offered / arranged.
  • The woman should be given the current RCOG Patient Leaflet on VBAC and the GGC Elective Caesarean Section leaflet early in her antenatal care and invited to return with any questions at a subsequent clinic appointment.
  • Consultant opinion should be sought regarding their preferences about IOL in VBAC cases BEFORE discussion with woman. Ideally, any woman considering IOL after a previous Caesarean Section should be reviewed by their consultant. She is entitled to seek a second opinion.
  • Women who have had two or more caesarean sections should be counselled by a senior obstetrician. This counselling should include detailed risks of uterine rupture and maternal morbidity. We would not usually offer these women IOL.
  • A plan should be documented in the casenotes by 34 weeks at the latest.
  • Complete and sign the Birth after Caesarean (VBAC vs ERCS) form (Appendix 1)

When is Elective Repeat Caesarean Section the optimal choice?

  • Offer elective CS to all classical UTERINE scars, ”T” or inverted “T” incisions and extensions of uterine scars that have a vertical component (i.e. not “lateral LUS extensions”).
  • Offer CS to women from overseas with vertical midline abdominal scars and who cannot be sure that they had a transverse lower segment uterine incision.
  • Offer CS to women who have absolute contraindications such as placenta praevia.
  • Consider factors that may increase the risk of uterine rupture – short inter-delivery interval (<12 months), post-date pregnancy, maternal age >40, obesity, macrosomia, twins.

Later antenatal care

  • Check that ultrasound localisation of placental site has been performed by 32 weeks.
  • Record Plan in notes PRIOR to Admission: document DATE and agreement of Consultant. Discuss VBAC again to ensure no new issues.
  • Await spontaneous labour and advise woman to contact Maternity Assessment Unit when she has regular or painful uterine activity - she will be advised to attend for assessment and management plan.
  • Review at 41 weeks: Offer cervical assessment and discuss risks of IOL in VBAC cases, dependent on method used. Make plan for either IOL or Elective Repeat Caesarean Section. If the choice for an elective repeat Caesarean section has been made by the patient, a plan including the section date should be documented in the notes together with a plan should she labour prior to her Caesarean section date.
  • If a woman wishing VBAC presents with prelabour rupture of membranes she should be reviewed/discussed with the on call consultant and an individual plan made.
  • All women wishing VBAC should be reviewed by medical staff when attending MAU in labour or with SROM.

INTRAPARTUM MANAGEMENT OF A VBAC CASE

  1. Medical review of woman and case notes/ Badgernet. Determine that there are no new contra-indications to VBAC. 
  2. Confirm VBAC request remains appropriate and that woman wishes this.
  3. There should be rigorous adherence to routine maternal observations.
  4. Continuous fetal heart rate monitoring is advised, commencing at the onset of regular uterine activity. (If the woman declines this, inform the on call Consultant and carefully document the details of the discussion between all parties).
  5. Obtain IV access.
  6. FBC, Group and Save (only cross match if specific indication – See Blood Ordering Schedule (Obstetrics)).
  7. Alert Anaesthetic registrar to VBAC. Epidural anaesthesia is not contraindicated in a VBAC labour, although the sudden requirement for increase in analgesic need may herald uterine rupture and usually needs a senior review.
  8. FIRST STAGE: Labour should be progressive on the basis of vaginal examination at least every 4 hours.
    • “Uterine inefficiency / incoordinate activity / abnormal contraction pattern” should all prompt careful consideration of entire case and whether VBAC attempt should be continued.
    • The use of augmentation by ARM and / or syntocinon must only be considered after a critical review of case and after discussion with Consultant Obstetrician (or equivalent). Women should be informed of the 2-3 fold risk of uterine rupture (although still very rare) and 1.5 fold increased risk of caesarean section when involving induction or augmentation of labour.
    • Syntocinon dose and rate increases are specified in relevant guideline and are lower than those used in primagravida’s (see Syntocinon guideline).

      HEED WARNING SIGNS:
    • Slow progress: first or second stage.
    • Atypical severe pain, especially if persisting between contractions: rupture can be preceded by all degrees and patterns of pain,.
    • Unexplained Maternal Tachycardia, hypotension, fainting.
    • Vaginal Bleeding.
    • Abnormal CTG.
    • Cessation of previously efficient uterine activity.
    • Loss of station of presenting part / change in abdominal contour.
  1. SECOND STAGE: This should be progressive and critical evaluation made after one hour.

Appendix 1 - Birth after Caesarean (VBAC vs ERCS) form

Editorial Information

Last reviewed: 08/11/2018

Next review date: 30/11/2023

Author(s): Julie Murphy.

Version: 3

Approved By: Obstetrics Clinical Governance Group

Document Id: 415

Related guidelines
References

www.nice.org.uk/CG013fullguideline

https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_45.pdf RCOG Green top guideline No. 45 Birth after Previous Caesarean Birth October 2015